Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Olema Pharmaceuticals (OLMA) Interest Expenses (2020)

Olema Pharmaceuticals (OLMA) has 1 years of Interest Expenses data on record, last reported at $653000.0 in Q1 2020.

  • On a quarterly basis, Interest Expenses changed N/A to $653000.0 in Q1 2020 year-over-year; TTM through Dec 2020 was $653000.0, a N/A change, with the full-year FY2020 number at $653000.0, changed N/A from a year prior.
  • Interest Expenses reached $653000.0 in Q1 2020 per OLMA's latest filing.
  • Over the last five years, Interest Expenses for OLMA hit a ceiling of $653000.0 in Q1 2020 and a floor of $653000.0 in Q1 2020.